External pneumatic compression does not increase urokinase plasminogen activator after abdominal surgery

Journal of Vascular Surgery

Volumn 36, Issue 5, 2002, Pages 917-921

  Murakami, Maki ^a,b   Wiley, Lara A ^a,b   Cindrick Pounds, Lori ^a,b   Hunter, Glenn C ^a,b   Uchida, Tatsuo ^a,b   Killewich, Lois A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; UROKINASE;

ABDOMINAL SURGERY; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL VEIN; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VENOUS BLOOD; VENOUS STASIS;

EID: 0036846556     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.128940     Document Type: Article

References (32)

1. Chen AH, Frangos SG, Kilaru S, Sumpio BE. Intermittent pneumatic compression devices: Physiological mechanisms of action. Eur J Vasc Endovasc Surg 2001;21:383-92.
2. Nicolaides AN, Miles C, Hoare M, Jury P, Helmis E, Venniker R. Intermittent sequential pneumatic compression of the legs and thromboembolism-deterrent stockings in the prevention of postoperative deep venous thrombosis. Surgery 1983;94:21-5.
3. Killewich LA, Sandager GP, Nguyen AH, Lilly MP, Flinn WK. Venous hemodynamics during impulse foot pumping. J Vasc Surg 1995;22:598-605.
4. Flam E, Berry S, Coyle A, Dardik H, Raab L. Blood-flow augmentation of intermittent pneumatic compression systems used for prevention of deep vein thrombosis prior to surgery. Am J Surg 1996;171:312-5.
5. Delis KT, Slimani G, Hafez HM, Nicolaides AN. Enhancing venous outflow in the lower limb with intermittent pneumatic compression. A comparative haemodynamic analysis on the effect of foot vs. calf vs. foot and calf compression. Eur J Vasc Endovasc Surg 2000;19:250-60.
6. Westrich GH, Specht LM, Sharrock NE, Sculco TP, Salvati EA, Pellicci PM, et al. Pneumatic compression hemodynamics in total hip arthroplasty. Clin Orthop 2000:180-91.
7. Tarnay TJ, Bohr PR, Davidson AG, Stevenson MM, Byars EF, Hopkins GR. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980;88:489-96.
8. Summaria L, McMillan R, Axelrod CA, Vagher JP, Fareed J. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg 1988;54:156-60.
9. Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R, et al. The fibrinolytic effects of intermittent pneumatic compression: Mechanism of enhanced fibrinolysis. Ann Surg 1997;226:306-14.
10. Christen Y, Wutschert R, Weimer D, de Moerloose P, Kruithof EK, Bounameaux H. Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity. Blood Coagul Fibrinolysis 1997;8:185-90.
11. Jacobs DG, Piotrowski JJ, Hoppensteadt DA, Salvator AE, Fareed J. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: Preliminary results. J Trauma 1996;40:710-17.
12. Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, et al. Prospective double-armed study of fibrinolysis in surgical patients. J Surg Res 1998;74:96-101.
13. Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery. J Vasc Surg 2000;32:537-43.
14. Solberg H, Ploug M, Hoyer-Hansen G, Nielsen BS, Lund LR. The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. J Histochem Cytochem 2001;49:237-46.
15. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 1997;72:1-22.
16. Lang IM, Marsh JJ, Konopka RG, Olman MA, Binder BR, Moser KM, et al. Factors contributing to increased vascular fibrinolytic activity in mongrel dogs. Circulation 1993;87:1990-2000.
17. Northeast AD, Soo KS, Bobrow LG, Gaffney PJ, Burnand KG. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 1995;22:573-9.
18. Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996;97:2440-51.
19. Levi M, Lensing AW, Buller HR, Prandoni P, Dooijewaard G, Cuppini S, et al. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release. Thromb Haemost 1991;66:426-9.
20. Dooijewaard G, Turion PNC, Cohen AF, Breimer DD, Kluft C. Physical exercise induces enhancement of urokinase-type plasminogen activator (uPA) levels in plasma. Thromb Haemost 1991;65:82-6.
21. Flinn WR, Silva MB Jr, Benjamin ME, Cerullo LJ, Taylor M. Prospective surveillance for perioperative venous thrombosis. Arch Surg 1996;131:142-80.
22. Pandolfi M, Nilsson IM, Robertson B, Isacson S. Fibrinolytic activity of human veins. Lancet 1967;2:127-8.
23. Allenby F, Pflug JJ, Calman JS. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet 1973;1:1412-4.
24. Knight MTN. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet 1976;2:1265-8.
25. Killewich LA, Cahan MA, Hanna DJ, Wiley L, Hunter CG. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg 2002;36:953-8.
26. Larsson LI, Skriver L, Nielsen LS, Grondahl-Hansen J, Kristensen P, Dano K. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 1984;98:894-903.
27. Grau E, Moroz LA. Fibrinolytic activity of normal human blood monocytes. Thromb Res 1989;53:145-62.
28. Gurewich V. Fibrinolysis: An unfinished agenda. Blood Coagul Fibrinolysis 2000;11:401-8.
29. Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986;261:3486-9.
30. Hauert J, Nicoloso G, Schleuning WD, Bachmann F, Schapira M. Plasminogen activators in dextran sulfate-activated euglobulin fractions: A molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis. Blood 1989;73:994-9.
31. Darras V, Thienpont M, Stump DC, Collen D. Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies. Thromb Haemost 1986;56:411-4.
32. Chouhan VD, Comerota AJ, Sun L, Harada R, Gaughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect. Arterioscler Thromb Vasc Biol 1999;19:2812-7.